ePRO: A Maturing and Widely-Preferred Market


Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-06-01-2013
Volume 22
Issue 6

Industry Standard Research

The adoption of technologies is generally increasing throughout clinical trials. It took the industry some time to fully adopt and integrate EDC as the de facto standard for data collection but that has happened. ISR's data show EDC is now the data collection method of choice for the vast majority of clinical trials. We're also witnessing the maturation of other technologies in clinical trials such as online dashboards that aggregate clinical trial metrics and report on study progress; we see clinical sites relying more heavily on their electronic medical records for feasibility and patient recruitment; and we find clinical investigators and study coordinators prefer electronic patient reported outcomes (ePRO) over paper PRO.

The stage is set for further proliferation of not only ePRO, but a much broader set of eClinical service offerings and value propositions. Service providers, technology developers, and CROs need to know where their products stand and sponsors should be aware of how their partners are viewed by one of the most important cogs in the clinical development wheel: the investigative sites.

—Industry Standard Research, www.ISRreports.com/.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.